These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6104906)

  • 1. The pituitary dopamine receptor.
    Labrie F; Di Paolo T; Raymond V; Ferland L; Beaulieu M
    Adv Biochem Psychopharmacol; 1980; 23():217-27. PubMed ID: 6104906
    [No Abstract]   [Full Text] [Related]  

  • 2. Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion.
    Annunziato L; Quattrone A; Schettini G; Di Renzo G
    Adv Biochem Psychopharmacol; 1980; 24():379-85. PubMed ID: 6105788
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
    Clement-Cormier Y
    Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists.
    De Lean A; Kilpatrick BF; Caron MG
    Mol Pharmacol; 1982 Sep; 22(2):290-7. PubMed ID: 7144730
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetrabenazine has properties of a dopamine receptor antagonist.
    Login IS; Cronin MJ; MacLeod RM
    Ann Neurol; 1982 Sep; 12(3):257-62. PubMed ID: 7137960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of benzamide drugs on prolactin secretion: relation to the dopamine receptor.
    Meltzer HY; So R; Fang VS
    Adv Biochem Psychopharmacol; 1982; 35():61-82. PubMed ID: 6756062
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors.
    Meltzer HY; Simonovic M; Fang V; Piyakalamala S; Young M
    Life Sci; 1978 Aug; 23(6):605-9. PubMed ID: 29199
    [No Abstract]   [Full Text] [Related]  

  • 8. No evidence for increased dopamine receptor binding in superresponsive mice after a single dose of neuroleptics.
    Hyttel J
    Adv Biochem Psychopharmacol; 1980; 24():167-73. PubMed ID: 6105773
    [No Abstract]   [Full Text] [Related]  

  • 9. Rat anterior pituitary dopaminergic receptors are regulated by estradiol and during lactation.
    Heiman ML; Ben-Jonathan N
    Endocrinology; 1982 Oct; 111(4):1057-60. PubMed ID: 7117191
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of 2 Hydroxyestradiol to interact with dopamine inhibition of human prolactin secretion in vitro and with dopamine receptors of prolactin-secreting adenomas.
    Peillon F; Brandi AM; Bression D; Le Dafniet M; Racadot J
    Biochem Biophys Res Commun; 1983 Apr; 112(1):42-6. PubMed ID: 6838618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neuroleptic drugs on endogenous opioid peptides in the rat.
    Höllt V
    Mod Probl Pharmacopsychiatry; 1981; 17():1-18. PubMed ID: 6120450
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology.
    Ferone D; Gatto F; Arvigo M; Resmini E; Boschetti M; Teti C; Esposito D; Minuto F
    J Mol Endocrinol; 2009 May; 42(5):361-70. PubMed ID: 19141603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of dopamine receptor binding by ascorbic acid.
    Madras BK; Chan B
    Adv Biochem Psychopharmacol; 1983; 37():275-87. PubMed ID: 6138950
    [No Abstract]   [Full Text] [Related]  

  • 15. [D-2 dopamine receptor and hormone release in the intermediate lobe of the pituitary gland].
    Munemura M
    Tanpakushitsu Kakusan Koso; 1986 Feb; 31(2):116-31. PubMed ID: 3014608
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitors of prolactin secretion: a mini-review.
    Slaunwhite WR
    Prog Clin Biol Res; 1981; 75B():19-29. PubMed ID: 6275411
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
    J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of fluperlapine compared with clozapine.
    Eichenberger E
    Arzneimittelforschung; 1984; 34(1A):110-3. PubMed ID: 6145425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative potency of some neuroleptics as antagonists at dopamine-receptors in vivo compared with their reported ability to displace haloperidol binding in vitro [proceedings].
    Cox B; Ennis C; Foote G
    Br J Pharmacol; 1980 Jan; 68(1):172P. PubMed ID: 6101975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.